Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Aeglea BioTherapeutics, Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-08-25
Purchase
2022-08-25
7:37 pm
Aeglea BioTherapeutics Inc.AGLESouza Marcio
Director
90,000$0.5608$50,47290,000
(Direct)
View
2022-06-08
Purchase
2022-06-10
6:24 pm
Aeglea BioTherapeutics Inc.AGLEHanley Jr. Michael Conick
Chief Commercial Officer
28,200$0.71$20,02236,200
(Direct)
View
2022-03-16
Purchase
2022-03-18
06:46 am
Aeglea BioTherapeutics Inc.AGLEQuinn Anthony G.
President & CEO
80,079$2.344$187,705816,835
(Indirect
Direct)
View
2022-03-11
Purchase
2022-03-15
6:32 pm
Aeglea BioTherapeutics Inc.AGLEQuinn Anthony G.
President & CEO
144,666$1.942$280,943739,756
(Indirect
Direct)
View
2022-03-11
Purchase
2022-03-15
6:30 pm
Aeglea BioTherapeutics Inc.AGLEAlspaugh Jonathan
Chief Financial Officer
75,000$2.08$156,000165,372
(Direct)
View
2021-12-09
Purchase
2021-12-13
8:41 pm
Aeglea BioTherapeutics Inc.AGLEShanafelt Armen
Director
150,000$3.6646$549,692150,000
(Direct)
View
2021-12-09
Purchase
2021-12-13
8:39 pm
Aeglea BioTherapeutics Inc.AGLEQuinn Anthony G.
President & CEO
53,634$3.7098$198,972595,090
(Indirect
Direct)
View
2021-12-09
Purchase
2021-12-13
8:37 pm
Aeglea BioTherapeutics Inc.AGLEAlspaugh Jonathan
Chief Financial Officer
50,000$3.72$186,00090,372
(Direct)
View
2021-08-16
Purchase
2021-08-18
5:21 pm
Aeglea BioTherapeutics Inc.AGLEAlspaugh Jonathan
Chief Financial Officer
40,372$6.506$262,66040,372
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-02-23
Option Award
2023-02-24
6:25 pm
N/A
2033-02-22
Aeglea BioTherapeutics Inc.AGLENeuman Linda L
Chief Medical Officer
550,000$0550,000
(Direct)
View
2023-02-23
Option Award
2023-02-24
6:24 pm
N/A
2033-02-22
Aeglea BioTherapeutics Inc.AGLEKastenmayer James Paul
General Counsel
500,000$0500,000
(Direct)
View
2023-02-23
Option Award
2023-02-24
6:22 pm
N/A
2033-02-22
Aeglea BioTherapeutics Inc.AGLEHanley Jr. Michael Conick
Chief Business Officer
500,000$0500,000
(Direct)
View
2023-02-23
Option Award
2023-02-24
6:20 pm
N/A
2033-02-22
Aeglea BioTherapeutics Inc.AGLEAlspaugh Jonathan
Chief Financial Officer
640,000$0640,000
(Direct)
View
2022-11-14
Option Award
2023-01-27
6:20 pm
N/A
2032-11-13
Aeglea BioTherapeutics Inc.AGLENeuman Linda L
Chief Medical Officer
25,000$025,000
(Direct)
View

Ownership
2023-01-27
6:18 pm
N/A
N/A
Aeglea BioTherapeutics Inc.AGLENeuman Linda L
Chief Medical Officer
0$0140,250
(Direct)
View
2022-11-29
Option Award
2022-12-01
8:47 pm
N/A
2032-11-28
Aeglea BioTherapeutics Inc.AGLEGoldberg Jeff Marc
President and CEO
1,884,838$01,884,838
(Direct)
View
2022-08-23
Option Award
2022-08-25
7:39 pm
N/A
2032-08-22
Aeglea BioTherapeutics Inc.AGLEKastenmayer James Paul
Interim CEO & General Counsel
130,000$0130,000
(Direct)
View

Ownership
2022-08-25
7:37 pm
N/A
N/A
Aeglea BioTherapeutics Inc.AGLEKastenmayer James Paul
Interim CEO & General Counsel
0$0219,000
(Direct)
View
2022-08-23
Option Award
2022-08-25
7:36 pm
N/A
2032-08-22
Aeglea BioTherapeutics Inc.AGLESloan Leslie
Chief Operating Officer
130,000$0130,000
(Direct)
View
2022-08-23
Option Award
2022-08-25
7:35 pm
N/A
2032-08-22
Aeglea BioTherapeutics Inc.AGLEHanley Jr. Michael Conick
Chief Business Officer
130,000$0130,000
(Direct)
View
2022-08-23
Option Award
2022-08-25
7:34 pm
N/A
2032-08-22
Aeglea BioTherapeutics Inc.AGLEAlspaugh Jonathan
Chief Financial Officer
130,000$0130,000
(Direct)
View
2022-06-07
Option Award
2022-06-10
06:04 am
N/A
2032-06-06
Aeglea BioTherapeutics Inc.AGLELawton Alison Frances
Director
43,000$043,000
(Direct)
View
2022-06-07
Option Award
2022-06-09
9:22 pm
N/A
2032-06-06
Aeglea BioTherapeutics Inc.AGLEShanafelt Armen
Director
43,000$043,000
(Direct)
View
2022-06-07
Option Award
2022-06-09
9:21 pm
N/A
2032-06-06
Aeglea BioTherapeutics Inc.AGLESouza Marcio
Director
43,000$043,000
(Direct)
View
2022-06-07
Option Award
2022-06-09
9:19 pm
N/A
2032-06-06
Aeglea BioTherapeutics Inc.AGLESmith Hunter C
Director
43,000$043,000
(Direct)
View
2022-06-07
Option Award
2022-06-09
9:18 pm
N/A
2032-06-06
Aeglea BioTherapeutics Inc.AGLEMahatme Sandesh
Director
43,000$043,000
(Direct)
View
2022-06-07
Option Award
2022-06-09
9:17 pm
N/A
2032-06-06
Aeglea BioTherapeutics Inc.AGLEMagovcevic-Liebisch Ivana
Director
43,000$043,000
(Direct)
View
2022-06-07
Option Award
2022-06-09
9:15 pm
N/A
2032-06-06
Aeglea BioTherapeutics Inc.AGLELAWLIS V BRYAN
Director
43,000$043,000
(Direct)
View
2022-06-07
Option Award
2022-06-09
9:13 pm
N/A
2032-06-06
Aeglea BioTherapeutics Inc.AGLECox Russell J.
Director
43,000$043,000
(Direct)
View
2022-02-17
Option Award
2022-02-22
4:57 pm
N/A
2032-02-16
Aeglea BioTherapeutics Inc.AGLEQuinn Anthony G.
President & CEO
350,000$0350,000
(Direct)
View
2022-02-17
Option Award
2022-02-22
4:55 pm
N/A
2032-02-16
Aeglea BioTherapeutics Inc.AGLEWeber Steven
VP, Controller&Princ Acctg Off
30,000$030,000
(Direct)
View
2022-02-17
Option Award
2022-02-22
4:54 pm
N/A
2032-02-16
Aeglea BioTherapeutics Inc.AGLESloan Leslie
Chief Operating Officer
180,000$0180,000
(Direct)
View
2022-02-17
Option Award
2022-02-22
4:51 pm
N/A
2032-02-16
Aeglea BioTherapeutics Inc.AGLEHanley Jr. Michael Conick
Chief Commercial Officer
160,000$0160,000
(Direct)
View
2022-02-17
Option Award
2022-02-22
4:50 pm
N/A
2032-02-16
Aeglea BioTherapeutics Inc.AGLEAlspaugh Jonathan
Chief Financial Officer
170,000$0170,000
(Direct)
View
2018-12-28
Ownership
2022-02-14
5:19 pm
N/A
N/A
Aeglea BioTherapeutics Inc.AGLEQuinn Anthony G.
President & CEO
266,295$0537,640
(Direct)
View
2021-11-12
Option Award
2021-11-16
4:34 pm
N/A
2031-11-11
Aeglea BioTherapeutics Inc.AGLESmith Hunter C
Director
60,000$060,000
(Direct)
View
2021-07-06
Option Award
2021-07-08
5:12 pm
N/A
2031-07-05
Aeglea BioTherapeutics Inc.AGLEAlspaugh Jonathan
Chief Financial Officer
160,000$0160,000
(Direct)
View
Goto 0, 1, 2, Next